Vaginal Hysterectomy utilizing the PlasmaSeal Open Forceps presented by Kristi Keil, MD.

PURPOSE: Laparoscopic partial nephrectomy (LPN) is an alternative modality of treatment for small sized renal cell carcinoma. Robot assisted laparoscopic partial nephrectomy (RLPN) has also been performed with an advantage in repairing resected surface after tumor resection. We compare the periopera...

tive data of patients treated with laparoscopic partial nephrectomy with those of RLPN undertaken patients. MATERIAL AND METHOD: From September 2006 to April 2008, 22 patients were treated with LPN and 22 were RLPN. 3 arms were used for RLPN; camera was inserted through the 12mm, umbilical trocar port. The laparoscopic Bulldog clamp was used for the clamping of renal hilum. We retrospectively compared each group about tumor size, operation time, estimated blood loss, warm ischemic time and hospital stay. RESULT: Operation time of LPN was shorter than that of RLPN (p=0.033). Tumor size, estimated blood loss and hospital stay was not significant different in each group. No case had conversion to open surgery. 1 patient of RLPN group, however, had conversion to radical nephrectomy due to severe bleeding. CONCLUSION: RLPN was safe and feasible in small sized renal cell carcinoma. Warm ischemic time was reasonable and morbidity associated with RLPN was also low. RLPN LPN p-value Tumor Size (cm) 2.5 2.1 0.605 Op time (min) 169.3 140.8 0.033 EBL (ml) 243.2 213.2 0.878 Warm Ischemic Time (min) 29.2 26.4 0.237 Transfusion (%) 4.5 4.5 0.756 Hospital stay (day) 4.4 5.5 0.053

After Sammyra’s knee injury, Marvin Smith, MD, orthopaedic surgeon at Memorial Sports Medicine Center, helped her get back on the volleyball court and playing pain free. Following a thorough examination, meniscus surgery and rehabilitation got Sammyra back to playing with her college team within two months. Learn more about how Memorial Sports Medicine Center helps athletes move forward at MHS.net/SportsMedicine.
To learn more about Dr. Smith, visit his physician profile page at: https://www.mhs.net/physicians/s/smith-marvin-k

Gastric Lavage Video

39 Yr. Male with Aortic Stenosis and Incompetance and Good LV Function. The Patient is an athlete and did not want to take oral anticoagulants so opted out for a Bio-prosthesis. A 23mm Hancock II Porcine Xenograft was used in this operation. Usually central aortic and Rt. Atrial cannulation is per...formed with this procedure, however on occasions Percutaneous (Seldinger Technique) Femoro Femoral artery cannulation is used. The Kit is manufactured by DLP and consists of a 20mm Arterial cannula and a 29mm two stage Rt. Atrial Cannula.

The hepatitis E virus, responsible for major epidemics of viral hepatitis in subtropical and tropical countries, was cloned only 7 years ago.1 Hepatitis E was found to belong to the family of Caliciviridae, which includes the Norwalk virus—a common cause of gastroenteritis in humans—and consists of a single, plus-strand RNA genome of approximately 7.2 kb without an envelope (Fig. 1). The virus contains at least three open reading frames encoding viral proteins against which antibodies are made on exposure. These antibodies, especially those against the capsid protein derived from the second open reading frame2 and a protein of unknown function derived from the third open reading frame, are detected by currently available serologic assays. Retrospective studies on stored sera of past epidemics of viral hepatitis in Mexico, Africa, Afghanistan, Pakistan, India, Bangladesh, Burma, Nepal, and Borneo have revealed that all were caused by strains of hepatitis E. In addition, hepatitis E was found to be responsible for the hepatitis epidemic in the southern part of Xinjiang, China, in which 120,000 persons became infected between September 1986 and April 1988.3 Hepatitis E predominantly affects young adults (15 to 40 years old). The symptoms of hepatitis E are similar to those of hepatitis A. Frequently, a prodrome consisting of anorexia, nausea, low-grade fever, and right upper abdominal pain is present 3 to 7 days before jaundice develops. Aminotransferase levels peak (usually between 1,000 and 2,000 U/L) near the onset of symptoms; bilirubin levels (10 to 20 mg/dL) peak later. Jaundice usually resolves after 1 to 2 weeks. In about 10% of cases, the disease is fulminant—especially in pregnant women, among whom mortality rates as high as 20% due to hemorrhagic and thrombotic complications have been reported. No evidence has suggested that hepatitis E can cause chronic infection. Transmission is by the fecal-oral route, predominantly through fecally contaminated drinking water supplies. In addition, however, preliminary reports have suggested transmission of the hepatitis E virus through blood transfusions. Volunteer studies confirmed the presence of the virus in serum and feces before and during clinical disease.4 The virus is shed into feces approximately 1 week before symptoms develop. The incubation period varies from 2 to 9 weeks (mean duration, approximately 45 days). Until now, a few reports had described symptomatic hepatitis E acquired in Europe;5, 6 all patients with symptomatic hepatitis E in the United States were travelers returning from Mexico, Africa, or the Far East, in whom hepatitis E developed after their return home.7 In this issue of the Mayo Clinic Proceedings (pages 1133 to 1136), Kwo and associates describe a case of hepatitis E in a man who had not left the United States during the previous 10 years. Specific serologic tests for hepatitis E virus IgG (enzyme immunoassays and a fluorescent antibody blocking assay) and IgM8 (US strain-specific enzyme-linked immunosorbent assay with use of synthetic polypeptides deduced from the viral genome, as shown in Figure 1), developed at Abbott Laboratories (IgG and IgM) as well as at the Centers for Disease Control and Prevention (IgG), were used to prove that the patient indeed had acute hepatitis E. Researchers at Abbott Laboratories have prepared a report that describes most of the viral genome in this patient (Fig. I).8 Their results are interesting because this strain from the United States differs considerably from hepatitis E strains isolated in Mexico, Burma, Pakistan, or China. Furthermore, the sequence of the US strain is highly homologous (98% and 94% homology at the amino acid level to the second and third open reading frames, respectively) to a recently isolated hepatitis E strain from American swine.9 This finding suggests that, in the United States, hepatitis E is a zoonosis with the swine population as one of its hosts. This relationship would confirm earlier studies in Asia, where swine were also found to carry variants of the hepatitis E virus.10 Why are these two recent discoveries important for medicine in the United States? First, other sporadic, locally acquired cases of acute hepatitis may be caused by hepatitis E. Second, these back-to-back discoveries strongly suggest that a common natural host for hepatitis E is present in countries with more moderate climates. Because swine do not seem to experience any symptoms associated with infection and because symptoms in humans can be minor or absent, we now may also have an explanation for the 1 to 2% of positive hepatitis E serologic results in blood donors in the United States,11 Netherlands,12 and Italy,6 countries with large swine staples. Clearly, more research needs to be done to confirm this hypothesis. Third, in countries with more moderate climates, hepatitis E may often result in a subclinical infection. Is this variation in manifestation due to less virulent strains, and do sequence variations determine virulence? Fourth, swine may be used as an animal model for study of the disease as well as vaccine development.

What is Esophageal Dilation?
Esophageal dilation is a procedure that allows your doctor to dilate, or stretch, a narrowed area of your esophagus [swallowing tube]. Doctors can use various techniques for this procedure. Your doctor might perform the procedure as part of a sedated endoscopy. Alternatively, your doctor might apply a local anesthetic spray to the back of your throat and then pass a weighted dilator through your mouth and into your esophagus.
Why is it Done?
The most common cause of narrowing of the esophagus, or stricture, is scarring of the esophagus from reflux of acid occurring in patients with heartburn. Patients with a narrowed portion of the esophagus often have trouble swallowing; food feels like it is "stuck" in the chest region, causing discomfort or pain. Less common causes of esophageal narrowing are webs or rings (which are thin layers of excess tissue), cancer of the esophagus, scarring after radiation treatment or a disorder of the way the esophagus moves [motility disorder].
How Should I Prepare for the Procedure?
An empty stomach allows for the best and safest examination, so you should have nothing to drink, including water, for at least six hours before the examination. Your doctor will tell you when to start fasting.
Tell your doctor in advance about any medications you take, particularly aspirin products or anticoagulants (blood thinners). Most medications can be continued as usual, but you might need to adjust your usual dose before the examination. Your doctor will give you specific guidance. Tell your doctor if you have any allergies to medications as well as medical conditions such as heart or lung disease. Also, tell your doctor if you require antibiotics prior to dental procedures, because you might need antibiotics prior to esophageal dilation as well.
What Can I Expect during Esophageal Dilation?
Your doctor might perform esophageal dilation with sedation along with an upper endoscopy. Your doctor may spray your throat with a local anesthetic spray, and then give you sedatives to help you relax. Your doctor then will pass the endoscope through your mouth and into the esophagus, stomach and duodenum. The endoscope does not interfere with your breathing. At this point your doctor will determine whether to use a dilating balloon or plastic dilators over a guiding wire to stretch your esophagus. You might experience mild pressure in the back of your throat or in your chest during the procedure. Alternatively, your doctor might start by spraying your throat with a local anesthetic. Your doctor will then pass a tapered dilating instrument through your mouth and guide it into the esophagus.
What Can I Expect after Esophageal Dilation?
After the dilation is done, you will probably be observed for a short period of time and then allowed to return to your normal activities. You may resume drinking when the anesthetic no longer causes numbness to your throat, unless your doctor instructs you otherwise. Most patients experience no symptoms after this procedure and can resume eating the next day, but you might experience a mild sore throat for the remainder of the day.
If you received sedatives, you probably will be monitored in a recovery area until you are ready to leave. You will not be allowed to drive after the procedure even though you might not feel tired. You should arrange for someone to accompany you home, because the sedatives might affect your judgment and reflexes for the rest of the day.
What are the Potential Complications of Esophageal Dilation?
Although complications can occur even when the procedure is performed correctly, they are rare when performed by doctors who are specially trained. A perforation, or hole, of the esophagus lining occurs in a small percentage of cases and may require surgery. A tear of the esophagus lining may occur and bleeding may result. Complications from heart or lung diseases are potential risks

Repair performed with the PROLIFT Pelvic Floor Repair System - the total implant. The objective of the PROLIFT procedure is to achieve a a complete anatomic repair of pelvic floor defects in a standardized way. The repair is achieved by the placement of the synthetic non-absorbable polyprolylen mesh... implant via a vaginal approach.

The Role of Insulin in the Human Body

Want to know how much smart lipo costs? Information on liposuction including liposuction costs, different liposuction techniques, recovery tips and much more.

Truncal Vagotomy and Pyloroplasty

急性坏疽性阑尾炎并穿孔de 腹腔镜手术治疗

Michael La Corte MD
Ped Card

Gallbladder "Lumigram" - shows the common bile duct(being probed) and the cystic duct (the duct YOU WANT TO CUT)

PARAPHARYNGEAL SPACE TUMORS: SURGICAL APPROACH

Histology of Vas Deferens

Hair removal techniques have come a long way since the days of messy creams, electrolysis, and shaving. At South Coast MedSpa, we use the most advanced laser technology to do the job efficiently, cleanly, and with minimal discomfort. The SCMS system is fast, gentle, safe, and effective for all skin types and colors.

This video contains five segments with best practices on how to prevent infection in patients with catheters, fistulas or grafts. It also includes segments on hand hygiene and glove use and dialysis station disinfection. The video is intended to be used by outpatient hemodialysis facilities as an educational tool to help remind their frontline staff, including technicians and nurses, about infection prevention measures. It can be used as an orientation video for new staff and as an annual in-service training tool to remind staff of proper protocols.

See the Spanish captioned version at: http://youtu.be/L5ypnOvOFMQ

Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia..../Tools/CommentPolicy

This video can also be viewed at http://streaming.cdc.gov/vod.p....hp?id=dc66d96228817d